Bleeding associated with co-administration of clopidogrel and ACEi in patients undergoing PCI and DAPT

Background and aims The coprescription of an angiotensin-converting enzyme inhibitor (ACEi) with clopidogrel reportedly increases bleeding risk. However, studies have not described such an increase in cases of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). Methods We analyzed electronic medical records of patients with discharge records of having undergone DAPT after PCI from a national health insurance claims...